Could an implant be the new weapon against opioid, heroin addiction?
The U.S. Food and Drug Administration is expected to decide this week whether to approve a new weapon in the war against heroin and prescription opioid addiction.
May 25, 2016
Archive: 25/05/2016
Salt Lake International Airport to phase out smoking rooms
The Salt Lake City International Airport is planning to get rid of smoking rooms to join more than 600 other airports that are already smoke-free.
May 25, 2016
What can Pavlov's dogs tell us about drinking?
Humans aren't much different from other animals. Just like Pavlov's dogs, we can become conditioned to associate environmental cues with rewards. Innocent enough when the sight of your sneakers makes you want to go for a ...
May 25, 2016
Study finds elevated cancer risk among women with new-onset atrial fibrillation
Among nearly 35,000 initially healthy women who were followed-up for about 20 years, those with new-onset atrial fibrillation had an increased risk of cancer, according to a study published online by JAMA Cardiology.
May 25, 2016
What are the timing and risk factors for suicide attempts in the army?
A new study that examined timing and risk factors for suicide attempts by U.S. Army-enlisted soldiers suggests risks were highest among those soldiers never deployed and that never-deployed soldiers were at greatest risk ...
May 25, 2016
Antiretroviral therapy may not be enough to reduce HIV-associated arterial inflammation
Initiating antiretroviral therapy (ART) soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in a small group of previously untreated patients. The findings from a ...
May 25, 2016
Lung function may affect vocal health for women
Teaching is an occupation with a high risk of developing vocal problems—teachers have more than twice the voice problems than people in other professions, as the voice is the major tool in classroom instruction and is often ...
May 25, 2016
FDA delay raises slim hope for muscular dystrophy drug
Federal health regulators will take more time to review a highly-contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine.
May 25, 2016
